Cannabis company Canopy applauds Biden’s marijuana pardons as stock surges

Cannabis company Canopy applauds Biden’s marijuana pardons as stock surges


Cannabis stocks surge as Biden pardons thousand convicted of marijuana possession

Canopy Growth applauded President Joe Biden’s announcement Thursday that he will pardon thousands of people convicted of marijuana possession.

“Today represents action from the Administration that we have been waiting for – an acknowledgement that cannabis prohibition has failed and that too many lives have been significantly impacted as a result,” David Culver, vice president of government relations Canopy, said in a statement.

Shares of the Canadian-based cannabis company, the world’s largest, jumped 22% after the news, closing at $3.75. Shares of fellow cannabis firm Tilray Brands gained over 30%. Tilray couldn’t be reached for comment by CNBC.

“President Biden, in keeping with his campaign commitments, has set into motion the actions needed to heal the harms of the past and chart a course for responsible, legal cannabis markets in the future,” Culver said.

Canopy Growth operations in Smiths Falls, Ontario.

Tom Franck | CNBC

The move could be a step toward a broad loosening of the federal classification of the drug. More than 6,500 individuals with prior convictions for simple marijuana possession were impacted by the pardons, according to the White House. This includes thousands more through pardons under D.C. law. 

“There are thousands of people who have prior federal convictions for marijuana possession, who may be denied employment, housing, or educational opportunities as a result. My action will help relieve the collateral consequences arising from these convictions,” Biden said in a statement announcing the pardons.

Biden urged governors to issue similar pardons for cases regarding state offenses of civil possession of marijuana.

In an earnings report Thursday morning, Constellation Brands, which owns 36% of Canopy’s outstanding shares, said it took a $1 billion writedown related to its stake in the cannabis company.

Canopy’s stock has fallen more than 70% in the last 12 months amid slowing sales across the cannabis industry. The stock is more than 90% off its all-time high of $56.89.

–CNBC’s Christina Wilkie contributed to this report.



Source

Trump nominates Erica Schwartz as CDC director amid turmoil around leadership, vaccine policy
Business

Trump nominates Erica Schwartz as CDC director amid turmoil around leadership, vaccine policy

Rear Admiral Erica G. Schwartz. U.S. Department of Health and Human Services President Donald Trump on Thursday nominated Erica Schwartz to serve as director of the Centers for Disease Control and Prevention, concluding a monthslong effort to choose a permanent leader of the embattled health agency.  Schwartz will have to be confirmed by the Senate, […]

Read More
RFK Jr.’s peptide policy could boost Hims & Hers as its GLP-1 business evolves
Business

RFK Jr.’s peptide policy could boost Hims & Hers as its GLP-1 business evolves

Piotr Swat | Lightrocket | Getty Images As its high-margin compounded GLP-1 business evolves, Hims & Hers Health may be finding a new opportunity in peptides. Shares of the telehealth company jumped Thursday after HHS Secretary Robert F. Kennedy Jr. announced Wednesday that the FDA plans to convene a Pharmacy Compounding Advisory Committee meeting to […]

Read More
Netflix reports earnings after the bell. Here’s what to expect
Business

Netflix reports earnings after the bell. Here’s what to expect

The Netflix logo is seen on an office building in Los Angeles, California, on Feb. 5, 2026. Michael Yanow | Nurphoto | Getty Images Netflix kicks off earnings season for media companies on Thursday with a quarterly report that Wall Street hopes will give more updates on the company’s path forward after walking away from […]

Read More